Advertisement
Advertisement

UPB

UPB logo

Upstream Bio, Inc. Common Stock

9.36
USD
Sponsored
+0.41
+4.58%
May 13, 16:00 UTC -4
Closed
exchange

Pre-Market

9.29

-0.07
-0.75%

Upstream Bio, Inc. Common Stock Profile

About

Upstream Bio Inc. is a clinical-stage biotechnology company developing treatments for inflammatory diseases, with an initial focus on severe respiratory disorders. The Company is developing verekitug, the only known antagonist currently in development which targets the receptor for thymic stromal lymphopoietin, a cytokine which is a clinically validated driver of inflammatory response positioned upstream of multiple signaling cascades that affect a variety of immune mediated diseases. Upstream Bio Inc. is based in WALTHAM, Mass.

Info & Links

CEO

E. Rand Sutherland

Headquarters

890 Winter Street, Suite 200
Waltham, MA 02451, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.upstreambio.com

Auditor

PricewaterhouseCoopers LLP

Share holders

3

Employees

75

Upstream Bio, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

505.56M

Enterprise Value

403.98M

Enterprise Value/EBITDA(ttm)

-2.50

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

198.69

Price to Book(mrq)

1.66

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

100.00%

Operating Margin(ttm)

-5026.03%

Profit Margin(ttm)

-5095.15%

Return on Equity(ttm)

-36.48%

Return on Invested Capital(ttm)

-37.31%

Return on Assets(ttm)

-35.38%

Income Statement

Revenue(ttm)

2.85M

Revenue Per Share(ttm)

0.05

Gross Profit(ttm)

2.85M

EBITDA(ttm)3

-161.68M

Net Income Available to Common(ttm)

-143.44M

Diluted EPS(ttm)

-2.67

Share Statistics

Beta (5Y Monthly)

1.80

52-Week Change

8.21%

S&P 500 52-Week Change

26.33%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

54.42M

Dividend Yield

0.00%

Float4

47.04M

% Held by Insiders

13.56%

% Held by Institutions

--

Balance Sheet

Total Cash(mrq)

341.51M

Total Cash Per Share(mrq)

6.28

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

26.15%

Quick Ratio(mrq)

26.15%

Book Value Per Share(mrq)

6.26

Cash Flow

Operating Cash Flow Per Share(ytd)

-2.47

Free Cash Flow(ytd)

-133.44M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement